Literature DB >> 14503969

Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34(+) cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial.

Massimo Di Nicola1, Carmelo Carlo-Stella, Andrea Anichini, Roberta Mortarini, Anna Guidetti, Gabrina Tragni, Francesco Gallino, Michele Del Vecchio, Fernando Ravagnani, Daniele Morelli, Paul Chaplin, Nathaly Arndtz, Gerd Sutter, Ingo Drexler, Giorgio Parmiani, Natale Cascinelli, Alessandro M Gianni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14503969     DOI： 10.1089/104303403322319426

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  6 in total

1.  Effects of herpes simplex virus amplicon transduction on murine dendritic cells.

Authors:  Yahui Grace Chiu; William J Bowers; Seung T Lim; Deborah A Ryan; Howard J Federoff
Journal:  Hum Gene Ther       Date:  2009-05       Impact factor: 5.695

2.  Cytokine-based high log-scale expansion of functional human dendritic cells from cord-blood CD34-positive cells.

Authors:  Yui Harada; Yae Okada-Nakanishi; Yasuji Ueda; Shunichi Tsujitani; Satoru Saito; Terumi Fuji-Ogawa; Akihiro Iida; Mamoru Hasegawa; Tomohiko Ichikawa; Yoshikazu Yonemitsu
Journal:  Sci Rep       Date:  2011-11-29       Impact factor: 4.379

Review 3.  Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?

Authors:  Ingo Drexler; Caroline Staib; Gerd Sutter
Journal:  Curr Opin Biotechnol       Date:  2004-12       Impact factor: 9.740

4.  Co-transfection of dendritic cells with AFP and IL-2 genes enhances the induction of tumor antigen-specific antitumor immunity.

Authors:  Jing-Yue Yang; Xiao Li; Li Gao; Zeng-Hui Teng; Wen-Chao Liu
Journal:  Exp Ther Med       Date:  2012-07-06       Impact factor: 2.447

5.  Type I interferon signaling limits viral vector priming of CD8+ T cells during initiation of vitiligo and melanoma immunotherapy.

Authors:  Rebecca L Riding; Jillian M Richmond; Keitaro Fukuda; John E Harris
Journal:  Pigment Cell Melanoma Res       Date:  2020-10-26       Impact factor: 4.159

6.  Modified vaccinia virus Ankara delivers a robust surrogate marker for immune monitoring to sarcoma cells even if cells are being exposed to chemotherapy and heat treatment.

Authors:  Katharina Tschoep-Lechner; Ingo Drexler; Doreen Hammer; Daniel Neumann; Heike Pohla; Gerd Sutter; Elfriede Noessner; Rolf-Dieter Issels
Journal:  Int J Hyperthermia       Date:  2012       Impact factor: 3.753
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.